Physician profile
Heidi Craddock
NPI 1588680714
$5,092.30
in general payments reported to CMS, 2019-2025
10 companies · $4,032 in 2025
The $4,032 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $101 · 2023: $211 · 2024: $612 · 2025: $4,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,797 · Travel and Lodging: $2,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,797.18 |
| Travel and Lodging | $2,057.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,399.74 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Gallant |
| Cvrx, INC. | $1,553.24 | 2024-2025 | Barostim Neo System |
| Abiomed | $454.27 | 2023-2025 | Impella |
| Scpharmaceuticals INC. | $257.17 | 2025 | |
| Amgen INC. | $175.58 | 2022-2024 | Repatha |
| Merck Sharp & Dohme LLC | $109.85 | 2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $42.62 | 2023 | Xarelto |
| Atricure, INC. | $41.13 | 2024 | |
| Medtronic, INC. | $33.89 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Craddock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.